Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000457

Type of data
NGS (Iso-seq, RNA-seq)
Access criteria
Controlled-access (Type I)
Total data volume
41.2 GB
File formats
  • FASTQ
Research
hum0094
Date published
2021-10-28
Date modified
2026-09-26
DDBJ Search
JGAD000457 (opens in a new tab)
JGA Study
JGAS000095 (opens in a new tab)

Analysis method

RNA-seq

Materials and participants
Triple negative breast cancer (ICD10: C50): 23 cases (including 2 cases for JGAD000457)
  • Health status
    Affected
  • Subject count
    2 (Individual)
Disease
Triple negative breast cancer (C50)
Sample description
RNAs extracted from tumor tissues
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
NEBNext Ultra Directional RNA Library Prep Kit for Illumina
TruSeq RNA Exome
Fragmentation
Heat treatment
Platform
Illumina HiSeq 2000
Illumina HiSeq 2500
Read type
Paired-end
Read length
Breast cancer: 100 bp
Data use policy
NBDC data sharing policy (JGAP000001)
No use by private-sector companies (JGAP000003)

Iso-seq

Materials and participants
Triple negative breast cancer (ICD10: C50): 14 cases
Estrogen receptor-positive breast cancer (ICD10: C50): 8 cases
  • Health status
    Affected
  • Subject count
    22 (Individual)
Disease
Triple negative breast cancer (C50)
Estrogen receptor-positive breast cancer (C50)
Sample description
RNAs extracted from tumor tissues
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
Iso-seq
Target
N/A
Reagent kit
SMRTbell Template Prep Kit 1.0
Fragmentation
N/A
Platform
PacBio Sequel
Read type
Single-end
Read length
N/A
Data use policy
NBDC data sharing policy (JGAP000001)